nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—ovarian cancer	0.472	1	CbGaD
Tolvaptan—ABCB1—Topotecan—ovarian cancer	0.075	0.221	CbGbCtD
Tolvaptan—ABCB1—Vinorelbine—ovarian cancer	0.0528	0.156	CbGbCtD
Tolvaptan—CYP3A4—Topotecan—ovarian cancer	0.0449	0.133	CbGbCtD
Tolvaptan—ABCB1—Paclitaxel—ovarian cancer	0.0371	0.11	CbGbCtD
Tolvaptan—CYP3A4—Vinorelbine—ovarian cancer	0.0317	0.0935	CbGbCtD
Tolvaptan—ABCB1—Docetaxel—ovarian cancer	0.0268	0.0792	CbGbCtD
Tolvaptan—CYP3A4—Paclitaxel—ovarian cancer	0.0222	0.0657	CbGbCtD
Tolvaptan—ABCB1—Doxorubicin—ovarian cancer	0.02	0.0591	CbGbCtD
Tolvaptan—CYP3A4—Docetaxel—ovarian cancer	0.0161	0.0475	CbGbCtD
Tolvaptan—CYP3A4—Doxorubicin—ovarian cancer	0.012	0.0354	CbGbCtD
Tolvaptan—Blood creatinine increased—Paclitaxel—ovarian cancer	0.000635	0.00336	CcSEcCtD
Tolvaptan—Angiopathy—Vinorelbine—ovarian cancer	0.000633	0.00334	CcSEcCtD
Tolvaptan—Dehydration—Paclitaxel—ovarian cancer	0.00063	0.00333	CcSEcCtD
Tolvaptan—Immune system disorder—Vinorelbine—ovarian cancer	0.00063	0.00333	CcSEcCtD
Tolvaptan—Mediastinal disorder—Vinorelbine—ovarian cancer	0.000628	0.00332	CcSEcCtD
Tolvaptan—Anorexia—Chlorambucil—ovarian cancer	0.00062	0.00328	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.000619	0.00327	CcSEcCtD
Tolvaptan—Breast disorder—Paclitaxel—ovarian cancer	0.000613	0.00324	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.00061	0.00323	CcSEcCtD
Tolvaptan—Malnutrition—Vinorelbine—ovarian cancer	0.000607	0.00321	CcSEcCtD
Tolvaptan—Renal impairment—Docetaxel—ovarian cancer	0.000604	0.00319	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.0006	0.00317	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.000598	0.00316	CcSEcCtD
Tolvaptan—Discomfort—Topotecan—ovarian cancer	0.000597	0.00315	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000587	0.0031	CcSEcCtD
Tolvaptan—Anaphylactic shock—Topotecan—ovarian cancer	0.000579	0.00306	CcSEcCtD
Tolvaptan—Hyponatraemia—Docetaxel—ovarian cancer	0.000577	0.00305	CcSEcCtD
Tolvaptan—Hyperuricaemia—Epirubicin—ovarian cancer	0.000575	0.00304	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Docetaxel—ovarian cancer	0.000575	0.00304	CcSEcCtD
Tolvaptan—Nervous system disorder—Topotecan—ovarian cancer	0.000568	0.003	CcSEcCtD
Tolvaptan—Anaphylactic shock—Melphalan—ovarian cancer	0.000567	0.003	CcSEcCtD
Tolvaptan—Decreased appetite—Chlorambucil—ovarian cancer	0.000565	0.00299	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Epirubicin—ovarian cancer	0.000564	0.00298	CcSEcCtD
Tolvaptan—Ill-defined disorder—Vinorelbine—ovarian cancer	0.000563	0.00298	CcSEcCtD
Tolvaptan—Skin disorder—Topotecan—ovarian cancer	0.000562	0.00297	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000562	0.00297	CcSEcCtD
Tolvaptan—Anorexia—Topotecan—ovarian cancer	0.000552	0.00292	CcSEcCtD
Tolvaptan—Skin disorder—Melphalan—ovarian cancer	0.000551	0.00291	CcSEcCtD
Tolvaptan—Malaise—Vinorelbine—ovarian cancer	0.000547	0.00289	CcSEcCtD
Tolvaptan—Blood uric acid increased—Epirubicin—ovarian cancer	0.000544	0.00287	CcSEcCtD
Tolvaptan—Pollakiuria—Paclitaxel—ovarian cancer	0.000541	0.00286	CcSEcCtD
Tolvaptan—Anorexia—Melphalan—ovarian cancer	0.00054	0.00286	CcSEcCtD
Tolvaptan—Feeling abnormal—Chlorambucil—ovarian cancer	0.000536	0.00283	CcSEcCtD
Tolvaptan—Dehydration—Docetaxel—ovarian cancer	0.000534	0.00282	CcSEcCtD
Tolvaptan—Pulmonary embolism—Epirubicin—ovarian cancer	0.000534	0.00282	CcSEcCtD
Tolvaptan—Hyperuricaemia—Doxorubicin—ovarian cancer	0.000532	0.00281	CcSEcCtD
Tolvaptan—Hyperglycaemia—Paclitaxel—ovarian cancer	0.000528	0.00279	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Docetaxel—ovarian cancer	0.000525	0.00277	CcSEcCtD
Tolvaptan—Hyperkalaemia—Epirubicin—ovarian cancer	0.000524	0.00277	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Doxorubicin—ovarian cancer	0.000522	0.00276	CcSEcCtD
Tolvaptan—Breast disorder—Docetaxel—ovarian cancer	0.000519	0.00274	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000517	0.00273	CcSEcCtD
Tolvaptan—Body temperature increased—Chlorambucil—ovarian cancer	0.000514	0.00272	CcSEcCtD
Tolvaptan—Renal failure—Paclitaxel—ovarian cancer	0.000513	0.00271	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000513	0.00271	CcSEcCtD
Tolvaptan—Discomfort—Vinorelbine—ovarian cancer	0.00051	0.0027	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000507	0.00268	CcSEcCtD
Tolvaptan—Decreased appetite—Topotecan—ovarian cancer	0.000503	0.00266	CcSEcCtD
Tolvaptan—Blood uric acid increased—Doxorubicin—ovarian cancer	0.000503	0.00266	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Topotecan—ovarian cancer	0.0005	0.00264	CcSEcCtD
Tolvaptan—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000495	0.00262	CcSEcCtD
Tolvaptan—Constipation—Topotecan—ovarian cancer	0.000495	0.00262	CcSEcCtD
Tolvaptan—Pulmonary embolism—Doxorubicin—ovarian cancer	0.000494	0.00261	CcSEcCtD
Tolvaptan—Decreased appetite—Melphalan—ovarian cancer	0.000493	0.0026	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000489	0.00259	CcSEcCtD
Tolvaptan—Nervous system disorder—Vinorelbine—ovarian cancer	0.000486	0.00257	CcSEcCtD
Tolvaptan—Hyperkalaemia—Doxorubicin—ovarian cancer	0.000485	0.00257	CcSEcCtD
Tolvaptan—Ecchymosis—Epirubicin—ovarian cancer	0.000483	0.00255	CcSEcCtD
Tolvaptan—Skin disorder—Vinorelbine—ovarian cancer	0.000481	0.00254	CcSEcCtD
Tolvaptan—Hypersensitivity—Chlorambucil—ovarian cancer	0.000479	0.00253	CcSEcCtD
Tolvaptan—Feeling abnormal—Topotecan—ovarian cancer	0.000477	0.00252	CcSEcCtD
Tolvaptan—Anorexia—Vinorelbine—ovarian cancer	0.000472	0.0025	CcSEcCtD
Tolvaptan—Asthenia—Chlorambucil—ovarian cancer	0.000467	0.00247	CcSEcCtD
Tolvaptan—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000463	0.00245	CcSEcCtD
Tolvaptan—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000461	0.00244	CcSEcCtD
Tolvaptan—Pruritus—Chlorambucil—ovarian cancer	0.00046	0.00243	CcSEcCtD
Tolvaptan—Urethral disorder—Paclitaxel—ovarian cancer	0.00046	0.00243	CcSEcCtD
Tolvaptan—Body temperature increased—Topotecan—ovarian cancer	0.000458	0.00242	CcSEcCtD
Tolvaptan—Ecchymosis—Doxorubicin—ovarian cancer	0.000447	0.00236	CcSEcCtD
Tolvaptan—Diarrhoea—Chlorambucil—ovarian cancer	0.000445	0.00235	CcSEcCtD
Tolvaptan—Renal failure—Docetaxel—ovarian cancer	0.000435	0.0023	CcSEcCtD
Tolvaptan—Cardiac disorder—Paclitaxel—ovarian cancer	0.000435	0.0023	CcSEcCtD
Tolvaptan—Decreased appetite—Vinorelbine—ovarian cancer	0.000431	0.00228	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000428	0.00226	CcSEcCtD
Tolvaptan—Hypersensitivity—Topotecan—ovarian cancer	0.000427	0.00225	CcSEcCtD
Tolvaptan—Angiopathy—Paclitaxel—ovarian cancer	0.000425	0.00225	CcSEcCtD
Tolvaptan—Constipation—Vinorelbine—ovarian cancer	0.000424	0.00224	CcSEcCtD
Tolvaptan—Immune system disorder—Paclitaxel—ovarian cancer	0.000424	0.00224	CcSEcCtD
Tolvaptan—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000423	0.00223	CcSEcCtD
Tolvaptan—Hypersensitivity—Melphalan—ovarian cancer	0.000418	0.00221	CcSEcCtD
Tolvaptan—Asthenia—Topotecan—ovarian cancer	0.000415	0.0022	CcSEcCtD
Tolvaptan—Pruritus—Topotecan—ovarian cancer	0.00041	0.00217	CcSEcCtD
Tolvaptan—Malnutrition—Paclitaxel—ovarian cancer	0.000408	0.00216	CcSEcCtD
Tolvaptan—Feeling abnormal—Vinorelbine—ovarian cancer	0.000408	0.00216	CcSEcCtD
Tolvaptan—Renal impairment—Epirubicin—ovarian cancer	0.000407	0.00215	CcSEcCtD
Tolvaptan—Asthenia—Melphalan—ovarian cancer	0.000407	0.00215	CcSEcCtD
Tolvaptan—Pruritus—Melphalan—ovarian cancer	0.000401	0.00212	CcSEcCtD
Tolvaptan—Dysgeusia—Paclitaxel—ovarian cancer	0.0004	0.00211	CcSEcCtD
Tolvaptan—Hypoglycaemia—Epirubicin—ovarian cancer	0.000397	0.0021	CcSEcCtD
Tolvaptan—Diarrhoea—Topotecan—ovarian cancer	0.000396	0.00209	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000395	0.00209	CcSEcCtD
Tolvaptan—Urinary tract disorder—Docetaxel—ovarian cancer	0.000393	0.00207	CcSEcCtD
Tolvaptan—Body temperature increased—Vinorelbine—ovarian cancer	0.000392	0.00207	CcSEcCtD
Tolvaptan—Connective tissue disorder—Docetaxel—ovarian cancer	0.000391	0.00206	CcSEcCtD
Tolvaptan—Urethral disorder—Docetaxel—ovarian cancer	0.00039	0.00206	CcSEcCtD
Tolvaptan—Hyponatraemia—Epirubicin—ovarian cancer	0.000389	0.00206	CcSEcCtD
Tolvaptan—Diarrhoea—Melphalan—ovarian cancer	0.000388	0.00205	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.000388	0.00205	CcSEcCtD
Tolvaptan—Nausea—Chlorambucil—ovarian cancer	0.000386	0.00204	CcSEcCtD
Tolvaptan—Dizziness—Topotecan—ovarian cancer	0.000383	0.00202	CcSEcCtD
Tolvaptan—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000379	0.002	CcSEcCtD
Tolvaptan—Renal impairment—Doxorubicin—ovarian cancer	0.000377	0.00199	CcSEcCtD
Tolvaptan—Cardiac disorder—Docetaxel—ovarian cancer	0.000369	0.00195	CcSEcCtD
Tolvaptan—Malaise—Paclitaxel—ovarian cancer	0.000368	0.00195	CcSEcCtD
Tolvaptan—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000367	0.00194	CcSEcCtD
Tolvaptan—Syncope—Paclitaxel—ovarian cancer	0.000366	0.00193	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000366	0.00193	CcSEcCtD
Tolvaptan—Hypersensitivity—Vinorelbine—ovarian cancer	0.000365	0.00193	CcSEcCtD
Tolvaptan—Blood creatinine increased—Epirubicin—ovarian cancer	0.000363	0.00192	CcSEcCtD
Tolvaptan—Headache—Topotecan—ovarian cancer	0.000363	0.00192	CcSEcCtD
Tolvaptan—Angiopathy—Docetaxel—ovarian cancer	0.000361	0.00191	CcSEcCtD
Tolvaptan—Dehydration—Epirubicin—ovarian cancer	0.00036	0.0019	CcSEcCtD
Tolvaptan—Hyponatraemia—Doxorubicin—ovarian cancer	0.00036	0.0019	CcSEcCtD
Tolvaptan—Immune system disorder—Docetaxel—ovarian cancer	0.000359	0.0019	CcSEcCtD
Tolvaptan—Loss of consciousness—Paclitaxel—ovarian cancer	0.000359	0.0019	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000359	0.0019	CcSEcCtD
Tolvaptan—Mediastinal disorder—Docetaxel—ovarian cancer	0.000358	0.00189	CcSEcCtD
Tolvaptan—Asthenia—Vinorelbine—ovarian cancer	0.000355	0.00188	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000354	0.00187	CcSEcCtD
Tolvaptan—Pruritus—Vinorelbine—ovarian cancer	0.00035	0.00185	CcSEcCtD
Tolvaptan—Breast disorder—Epirubicin—ovarian cancer	0.00035	0.00185	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000349	0.00184	CcSEcCtD
Tolvaptan—Malnutrition—Docetaxel—ovarian cancer	0.000346	0.00183	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000345	0.00182	CcSEcCtD
Tolvaptan—Nausea—Topotecan—ovarian cancer	0.000344	0.00182	CcSEcCtD
Tolvaptan—Discomfort—Paclitaxel—ovarian cancer	0.000343	0.00181	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000342	0.00181	CcSEcCtD
Tolvaptan—Dry mouth—Paclitaxel—ovarian cancer	0.00034	0.0018	CcSEcCtD
Tolvaptan—Diarrhoea—Vinorelbine—ovarian cancer	0.000339	0.00179	CcSEcCtD
Tolvaptan—Dysgeusia—Docetaxel—ovarian cancer	0.000339	0.00179	CcSEcCtD
Tolvaptan—Nausea—Melphalan—ovarian cancer	0.000337	0.00178	CcSEcCtD
Tolvaptan—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000336	0.00178	CcSEcCtD
Tolvaptan—Dehydration—Doxorubicin—ovarian cancer	0.000333	0.00176	CcSEcCtD
Tolvaptan—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000333	0.00176	CcSEcCtD
Tolvaptan—Shock—Paclitaxel—ovarian cancer	0.000328	0.00173	CcSEcCtD
Tolvaptan—Dizziness—Vinorelbine—ovarian cancer	0.000328	0.00173	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000327	0.00173	CcSEcCtD
Tolvaptan—Nervous system disorder—Paclitaxel—ovarian cancer	0.000327	0.00173	CcSEcCtD
Tolvaptan—Breast disorder—Doxorubicin—ovarian cancer	0.000324	0.00171	CcSEcCtD
Tolvaptan—Skin disorder—Paclitaxel—ovarian cancer	0.000324	0.00171	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000323	0.00171	CcSEcCtD
Tolvaptan—Anorexia—Paclitaxel—ovarian cancer	0.000318	0.00168	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000316	0.00167	CcSEcCtD
Tolvaptan—Headache—Vinorelbine—ovarian cancer	0.00031	0.00164	CcSEcCtD
Tolvaptan—Syncope—Docetaxel—ovarian cancer	0.00031	0.00164	CcSEcCtD
Tolvaptan—Pollakiuria—Epirubicin—ovarian cancer	0.000309	0.00164	CcSEcCtD
Tolvaptan—Loss of consciousness—Docetaxel—ovarian cancer	0.000304	0.00161	CcSEcCtD
Tolvaptan—Hyperglycaemia—Epirubicin—ovarian cancer	0.000302	0.0016	CcSEcCtD
Tolvaptan—Nausea—Vinorelbine—ovarian cancer	0.000294	0.00156	CcSEcCtD
Tolvaptan—Renal failure—Epirubicin—ovarian cancer	0.000294	0.00155	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000293	0.00155	CcSEcCtD
Tolvaptan—Decreased appetite—Paclitaxel—ovarian cancer	0.00029	0.00153	CcSEcCtD
Tolvaptan—Dry mouth—Docetaxel—ovarian cancer	0.000288	0.00152	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000288	0.00152	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—ovarian cancer	0.000286	0.00151	CcSEcCtD
Tolvaptan—Constipation—Paclitaxel—ovarian cancer	0.000285	0.00151	CcSEcCtD
Tolvaptan—Anaphylactic shock—Docetaxel—ovarian cancer	0.000282	0.00149	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00028	0.00148	CcSEcCtD
Tolvaptan—Shock—Docetaxel—ovarian cancer	0.000278	0.00147	CcSEcCtD
Tolvaptan—Nervous system disorder—Docetaxel—ovarian cancer	0.000277	0.00146	CcSEcCtD
Tolvaptan—Feeling abnormal—Paclitaxel—ovarian cancer	0.000275	0.00145	CcSEcCtD
Tolvaptan—Skin disorder—Docetaxel—ovarian cancer	0.000274	0.00145	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—ovarian cancer	0.000272	0.00144	CcSEcCtD
Tolvaptan—Anorexia—Docetaxel—ovarian cancer	0.000269	0.00142	CcSEcCtD
Tolvaptan—Urinary tract disorder—Epirubicin—ovarian cancer	0.000265	0.0014	CcSEcCtD
Tolvaptan—Connective tissue disorder—Epirubicin—ovarian cancer	0.000263	0.00139	CcSEcCtD
Tolvaptan—Body temperature increased—Paclitaxel—ovarian cancer	0.000263	0.00139	CcSEcCtD
Tolvaptan—Urethral disorder—Epirubicin—ovarian cancer	0.000263	0.00139	CcSEcCtD
Tolvaptan—Cardiac disorder—Epirubicin—ovarian cancer	0.000249	0.00132	CcSEcCtD
Tolvaptan—Decreased appetite—Docetaxel—ovarian cancer	0.000245	0.0013	CcSEcCtD
Tolvaptan—Hypersensitivity—Paclitaxel—ovarian cancer	0.000245	0.0013	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000245	0.00129	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000244	0.00129	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000244	0.00129	CcSEcCtD
Tolvaptan—Angiopathy—Epirubicin—ovarian cancer	0.000243	0.00129	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—ovarian cancer	0.000243	0.00129	CcSEcCtD
Tolvaptan—Immune system disorder—Epirubicin—ovarian cancer	0.000242	0.00128	CcSEcCtD
Tolvaptan—Mediastinal disorder—Epirubicin—ovarian cancer	0.000242	0.00128	CcSEcCtD
Tolvaptan—Constipation—Docetaxel—ovarian cancer	0.000241	0.00128	CcSEcCtD
Tolvaptan—Asthenia—Paclitaxel—ovarian cancer	0.000239	0.00126	CcSEcCtD
Tolvaptan—Pruritus—Paclitaxel—ovarian cancer	0.000236	0.00125	CcSEcCtD
Tolvaptan—Malnutrition—Epirubicin—ovarian cancer	0.000233	0.00123	CcSEcCtD
Tolvaptan—Feeling abnormal—Docetaxel—ovarian cancer	0.000233	0.00123	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—ovarian cancer	0.00023	0.00122	CcSEcCtD
Tolvaptan—Dysgeusia—Epirubicin—ovarian cancer	0.000229	0.00121	CcSEcCtD
Tolvaptan—Diarrhoea—Paclitaxel—ovarian cancer	0.000228	0.0012	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—ovarian cancer	0.000225	0.00119	CcSEcCtD
Tolvaptan—Immune system disorder—Doxorubicin—ovarian cancer	0.000224	0.00118	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000224	0.00118	CcSEcCtD
Tolvaptan—Body temperature increased—Docetaxel—ovarian cancer	0.000223	0.00118	CcSEcCtD
Tolvaptan—Dizziness—Paclitaxel—ovarian cancer	0.00022	0.00116	CcSEcCtD
Tolvaptan—Ill-defined disorder—Epirubicin—ovarian cancer	0.000217	0.00114	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—ovarian cancer	0.000216	0.00114	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—ovarian cancer	0.000211	0.00112	CcSEcCtD
Tolvaptan—Malaise—Epirubicin—ovarian cancer	0.00021	0.00111	CcSEcCtD
Tolvaptan—Syncope—Epirubicin—ovarian cancer	0.000209	0.00111	CcSEcCtD
Tolvaptan—Headache—Paclitaxel—ovarian cancer	0.000209	0.0011	CcSEcCtD
Tolvaptan—Hypersensitivity—Docetaxel—ovarian cancer	0.000208	0.0011	CcSEcCtD
Tolvaptan—Loss of consciousness—Epirubicin—ovarian cancer	0.000205	0.00108	CcSEcCtD
Tolvaptan—Asthenia—Docetaxel—ovarian cancer	0.000203	0.00107	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—ovarian cancer	0.0002	0.00106	CcSEcCtD
Tolvaptan—Pruritus—Docetaxel—ovarian cancer	0.0002	0.00106	CcSEcCtD
Tolvaptan—Nausea—Paclitaxel—ovarian cancer	0.000198	0.00105	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000197	0.00104	CcSEcCtD
Tolvaptan—Discomfort—Epirubicin—ovarian cancer	0.000196	0.00104	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—ovarian cancer	0.000195	0.00103	CcSEcCtD
Tolvaptan—Dry mouth—Epirubicin—ovarian cancer	0.000194	0.00103	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—ovarian cancer	0.000194	0.00102	CcSEcCtD
Tolvaptan—Diarrhoea—Docetaxel—ovarian cancer	0.000193	0.00102	CcSEcCtD
Tolvaptan—Anaphylactic shock—Epirubicin—ovarian cancer	0.00019	0.00101	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—ovarian cancer	0.00019	0.001	CcSEcCtD
Tolvaptan—Shock—Epirubicin—ovarian cancer	0.000187	0.00099	CcSEcCtD
Tolvaptan—Nervous system disorder—Epirubicin—ovarian cancer	0.000187	0.000987	CcSEcCtD
Tolvaptan—Dizziness—Docetaxel—ovarian cancer	0.000187	0.000987	CcSEcCtD
Tolvaptan—Skin disorder—Epirubicin—ovarian cancer	0.000185	0.000978	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000183	0.000965	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—ovarian cancer	0.000182	0.00096	CcSEcCtD
Tolvaptan—Anorexia—Epirubicin—ovarian cancer	0.000182	0.00096	CcSEcCtD
Tolvaptan—Dry mouth—Doxorubicin—ovarian cancer	0.00018	0.00095	CcSEcCtD
Tolvaptan—Headache—Docetaxel—ovarian cancer	0.000177	0.000935	CcSEcCtD
Tolvaptan—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000176	0.000931	CcSEcCtD
Tolvaptan—Shock—Doxorubicin—ovarian cancer	0.000173	0.000916	CcSEcCtD
Tolvaptan—Nervous system disorder—Doxorubicin—ovarian cancer	0.000173	0.000913	CcSEcCtD
Tolvaptan—Skin disorder—Doxorubicin—ovarian cancer	0.000171	0.000905	CcSEcCtD
Tolvaptan—Anorexia—Doxorubicin—ovarian cancer	0.000168	0.000888	CcSEcCtD
Tolvaptan—Nausea—Docetaxel—ovarian cancer	0.000168	0.000887	CcSEcCtD
Tolvaptan—Decreased appetite—Epirubicin—ovarian cancer	0.000166	0.000875	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000164	0.000869	CcSEcCtD
Tolvaptan—Constipation—Epirubicin—ovarian cancer	0.000163	0.000861	CcSEcCtD
Tolvaptan—Feeling abnormal—Epirubicin—ovarian cancer	0.000157	0.00083	CcSEcCtD
Tolvaptan—Decreased appetite—Doxorubicin—ovarian cancer	0.000153	0.00081	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000152	0.000804	CcSEcCtD
Tolvaptan—Constipation—Doxorubicin—ovarian cancer	0.000151	0.000797	CcSEcCtD
Tolvaptan—Body temperature increased—Epirubicin—ovarian cancer	0.000151	0.000796	CcSEcCtD
Tolvaptan—Feeling abnormal—Doxorubicin—ovarian cancer	0.000145	0.000768	CcSEcCtD
Tolvaptan—Hypersensitivity—Epirubicin—ovarian cancer	0.00014	0.000742	CcSEcCtD
Tolvaptan—Body temperature increased—Doxorubicin—ovarian cancer	0.000139	0.000736	CcSEcCtD
Tolvaptan—Asthenia—Epirubicin—ovarian cancer	0.000137	0.000722	CcSEcCtD
Tolvaptan—Pruritus—Epirubicin—ovarian cancer	0.000135	0.000712	CcSEcCtD
Tolvaptan—Diarrhoea—Epirubicin—ovarian cancer	0.00013	0.000689	CcSEcCtD
Tolvaptan—Hypersensitivity—Doxorubicin—ovarian cancer	0.00013	0.000686	CcSEcCtD
Tolvaptan—Asthenia—Doxorubicin—ovarian cancer	0.000126	0.000668	CcSEcCtD
Tolvaptan—Dizziness—Epirubicin—ovarian cancer	0.000126	0.000666	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—ovarian cancer	0.000125	0.000659	CcSEcCtD
Tolvaptan—Diarrhoea—Doxorubicin—ovarian cancer	0.000121	0.000637	CcSEcCtD
Tolvaptan—Headache—Epirubicin—ovarian cancer	0.000119	0.000631	CcSEcCtD
Tolvaptan—Dizziness—Doxorubicin—ovarian cancer	0.000117	0.000616	CcSEcCtD
Tolvaptan—Nausea—Epirubicin—ovarian cancer	0.000113	0.000598	CcSEcCtD
Tolvaptan—Headache—Doxorubicin—ovarian cancer	0.00011	0.000584	CcSEcCtD
Tolvaptan—Nausea—Doxorubicin—ovarian cancer	0.000105	0.000553	CcSEcCtD
